Crossmark

A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms

Crossref DOI link: https://doi.org/10.1007/s12032-024-02473-8

Published Online: 2024-08-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alkan, Ayşe Hale https://orcid.org/0000-0001-9989-5796
Ensoy, Mine https://orcid.org/0000-0002-2197-1223
Cansaran-Duman, Demet https://orcid.org/0000-0001-5662-2333
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (222S148, 222S148, 222S148)
License Information

Text and Data Mining valid from 2024-08-19

Version of Record valid from 2024-08-19
More Information

Article History

Received: 9 June 2024

Accepted: 7 August 2024

First Online: 19 August 2024

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below